United Therapeutics Corporation (UTHR)
NASDAQ · Healthcare
United Therapeutics Corporation Operating Income 2008–2025
United Therapeutics Corporation annual/quarterly operating income history and growth rate from 2008 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- United Therapeutics Corporation operating income for the quarter ending March 31, 2026 was 325.8 M, a 14.89% decrease year-over-year.
- United Therapeutics Corporation operating income for the twelve months ending March 31, 2026 was 1.5 B, a 8.56% increase year-over-year.
- United Therapeutics Corporation annual operating income for 2025 was 1.5 B, a 8.39% increase from 2024.
- United Therapeutics Corporation annual operating income for 2024 was 1.4 B, a 16.21% increase from 2023.
- United Therapeutics Corporation annual operating income for 2023 was 1.2 B, a 20.95% increase from 2022.
- United Therapeutics Corporation annual operating income for 2022 was 979.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
United Therapeutics Corporation Operating Income — FAQ
United Therapeutics Corporation (UTHR) operating income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is United Therapeutics Corporation's operating income?
United Therapeutics Corporation (UTHR) reported operating income of $1.49B for fiscal 2025.
Where can I see UTHR's operating income history?
The chart and table above show United Therapeutics Corporation's operating income by year and by quarter, including the growth rate.